Submitted by Anonymous (not verified) on 16 February 2026 - 13:42
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 01/07/2019, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 01/07/2019, Revision: 20, Status: Authorised